908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
908 Devices has raised $101.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2021.
908 Devices's investors include ARCH Venture Partners, Cormorant Asset Management, Sands Capital Ventures, SLB, UTEC - The University of Tokyo Edge Capital Partners.
908 Devices is headquartered in Boston, United States.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
908 Devices is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"908 Devices — Funding & Investors." VCBacked, November 10, 2021, https://www.vcbacked.co/company/908-devices. Accessed July 19, 2026.
VCBacked. (2021). 908 Devices — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/908-devices
{{cite web |title=908 Devices — Funding & Investors |url=https://www.vcbacked.co/company/908-devices |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated